December 2023 national news update: Lawmakers and canna-businesses push for reform 

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.

As the year draws to a close, the cannabis landscape across the nation witnesses an array of pivotal updates. This blog explores these year-end developments, unraveling the initiative threads that weave together policy, public opinion, and legal intricacies within the dynamic realm of cannabis advocacy.
 

Medical cannabis access for veterans continues to be a part of spending bill negotiations

Bipartisan congressional lawmakers are urging the House of Representatives to ensure that a large-scale spending bill maintains language to allow U.S. Department of Veterans Affairs (VA) doctors to issue medical cannabis recommendations to veterans in states that have medical cannabis.

A letter sent to the House Appropriations Committee requested that leadership maintain this protection as a part of the final 2024 Military Construction, Veterans Affairs, and Related Agencies spending bill. 

Both the House and Senate included provisions in their respective Military Construction, Veterans Affairs, and Related Agencies (MilConVA) measures that would permit VA doctors to make medical cannabis recommendations, but the letter asks for the adoption of the Senate version that Sen. Jeff Merkley (D-OR) secured as a part of his chamber’s bill.  

“Thirty-eight states, the District of Columbia, and four U.S. territories have passed laws that provide for legal access to medical marijuana products,” reads the letter. “As a result, more than three million patients across the country, including many veterans, now use medical marijuana at the recommendation of their physician to treat conditions ranging from seizures, glaucoma, anxiety, chronic pain, nausea, and posttraumatic stress disorder (PTSD).”

Governors urge Biden to reschedule cannabis

Six state governors have jointly written a letter to President Joseph R. Biden, Jr., urging him to reschedule cannabis by the end of 2023. Signed by the governors of Colorado, Illinois, Louisiana, Maryland, New Jersey, and New York, the letter emphasizes that the rescheduling of cannabis would bring economic and tax advantages for cannabis businesses across the nation. It also highlights the potential to safeguard public health and bring government policy into closer alignment with public opinion. 

“Rescheduling cannabis aligns with a safe, regulated product that Americans can trust,” the letter reads. “As governors, we might disagree about whether recreational cannabis legalization or even cannabis use is a net positive, but we agree that the cannabis industry is here to stay, the states have created strong regulations, and supporting the state-regulated marketplace is essential for the safety of the American people.” 

The letter went on to explain that the recent Department of Health and Human Services (HHS) recommendation to reschedule cannabis “comes on the heels of 38 states creating their own state markets” and regulatory systems.

Feds and canna-businesses request extension on cannabis lawsuit 

A coalition of cannabis businesses agreed to request a deadline extension for the filing of a lawsuit that seeks to block the enforcement of cannabis prohibition against state-legal activities. 

Filed in the U.S. District Court for The District of Massachusetts, the lawsuit claims that enforcing prohibition in legal state-level markets is unconstitutional and creates public safety risks while preventing licensed businesses from accessing critical financial services and tax deductions. It alleges that while Congress initially prohibited cannabis through the Controlled Substances Act (CSA) to eradicate interstate commerce, lawmakers and the executive branch have since “abandoned” that mission as more states have enacted legalization.

The joint request says that the attorneys for state-licensed companies and the Justice Department mutually agreed to request that the court extend the deadline for the government’s response to the lawsuit by 28 days – pushing it from December 26th, 2023 to January 23rd, 2024. 

“The parties respectfully submit that these adjustments are warranted in light of the obligations of counsel in other litigation matters and the holiday season,” the document says. “The parties agree that these requested extensions are reasonable, will not prejudice any party, and will not unduly delay resolution of this matter.” 

Stay up to date with CWCBExpo 

As we bid farewell to the year, the complex tapestry of cannabis news and reform reveals itself in a series of significant developments. As you transition into the new year, look no further than CWCBExpo for comprehensive updates on the industry’s latest happenings nationwide. Join the in-person expo to immerse yourself in the pulse of our industry, or check out our website for all the latest updates. 

November 2023 Regional News Update: Triumphs in NJ and NY

Each month, Cannabis World Congress & Business Exposition (CWCBExpo) offers a convenient roundup of the biggest cannabis news stories and hemp headlines emerging across the nation. Get these updates in your inbox by subscribing to our email newsletter, or follow us on Instagram, LinkedIn, Facebook, or Twitter (now X) to get the most recent edition when it’s published.


Welcome to the November 2023 Regional News Update from CWCBExpo. This month’s edition brings major news regarding New York’s licensing program for adult-use cannabis businesses, as well as additional developments in the Empire State and New Jersey. Join us for a closer look at the headlines shaping the regional cannabis scene as the Northeast’s cannabis industry continues to flourish.


New York CAURD lawsuit settlement means licensing could soon resume


A settlement agreement has been reached in the lawsuits that led to a suspension of New York’s Conditional Adult-Use Retail Dispensary (CAURD) program. The terms have been approved by the state’s cannabis regulators, potentially clearing the way for hundreds of cannabis businesses that have faced operational hurdles due to the lawsuits and an injunction preventing the issuing of additional CAURD licenses.

During a recent meeting of the Cannabis Control Board (CCB), the group voted to approve an agreement to allow for the continuation of CAURD. While details remain confidential, the two lawsuits that would be resolved under the settlement are:  


  • Carmine Fiore, et al. v. New York State Cannabis Control Board: Filed by military veterans to address concerns over the exclusion of disabled veterans from social equity licensing prioritization. 
  • Coalition for Access to Regulated & Safe Cannabis v. New York State Cannabis Control Board: Filed by existing medical cannabis operators and prospective adult-use applicants to address the proper application of the state cannabis law. It asserts that regulators are misapplying the law and argues that current medical cannabis businesses should qualify for licensing as well.  

The agreement must now be presented to the New York Supreme Court for approval. If the state’s high court approves the settlement agreement, the issuance of CAURD licenses will resume and licensees will be allowed to open storefronts.

 

Office of Cannabis Management (OCM) Executive Director Chris Alexander said in a press release on Monday that NY is now “one step closer to resolving litigation brought forth by equity entrepreneurs and medical operators.”

 

“Now that we have opened up licensing to all equity entrepreneurs and provided a clear pathway to participation in the adult-use market for our medical operators, we are able to continue to move this program forward together,” Alexander said.

 

New York cannabis businesses can now take tax deductions 

 

New York Governor Kathy Hochul (D) has signed a bill allowing New York City cannabis businesses to deduct their business expenses for tax purposes. This measure will provide relief to those facing restrictions under the Internal Revenue Service (IRS) code known as 280E, which blocks them from making such deductions against their federal tax liability. 

 

Although Hochul did sign a budget bill last year to allow state-level cannabis business tax deduction, NYC’s own tax laws remained unaffected. The new legislation would address that limitation and enable city-based businesses to benefit from state tax deductions as well. However, cannabis businesses would still be unable to take such deductions against their federal tax bill as IRS Code Section 280E remains in place federally.

 

“This bill would allow a deduction for business expenses, incurred by taxpayers authorized by the Cannabis Law to engage in the sale, distribution, or production of adult-use cannabis products or medical cannabis, for purposes of the unincorporated business tax (UBT), the general corporation tax (GCT), and the corporate tax of 2015, commonly referred to as the business corporation tax (BCT),” a summary of the bill reads.

 

A section of the city’s tax code would be amended to add sections allowing the deductions “in an amount equal to any federal deduction disallowed by section 280E of the internal revenue code.” So, while cannabis businesses remain unable to take federal tax deductions available to other businesses, the bill would allow them to recoup those costs at the city and state levels.

 

New Jersey’s first veteran and Latina-owned dispensary opens in Jersey City 

 

The Cannabis Place, founded by retired U.S. Marine Osbert Orduña, celebrated the grand opening of its flagship dispensary in Jersey City on Nov. 9 at 4:20 p.m. The opening marks not only the state’s first veteran-owned dispensary but also its first Latino-owned establishment. 

 

“We picked this week to open [because] it is symbolic in many ways,” Orduña said in a statement. “I am an Iraq veteran, [it is] the Marine Corps birthday and Veterans Day, too. To add the opening of Jersey City’s first service-disabled veteran-owned business to this makes this week even more special to us and our team.”

 

Prior to the opening, The Cannabis Place announced the completion of the first-ever cannabis retail pre-apprenticeship training program in the United States, in partnership with the United Food and Commercial Workers International Union (UFCW) Local 360. The program currently includes 22 local students, who are learning the basics of working in cannabis retail from UFCW Local 360’s own experts. Each participant in the two-week pre-apprenticeship course is guaranteed a job with The Cannabis Place to complete the 2,000 hours required for the full apprenticeship program. 

 

“We want our business to serve the local community,” Orduña said. “That means running an ethical, unionized company and boosting the prospects and prosperity of our neighbors. This program does that and is more proof that workforce investment equals immediate positive community impact. People can start careers here, whatever their background and skill level, and regardless of their history.”

 

New York cannabis sales reach over $100 million

 

New York has officially surpassed $100 million in adult-use sales so far in 2023, according to the minutes of the Nov. 11 Cannabis Control Board (CCB) meeting. Despite a limited number of dispensaries (just 27 operational statewide since legalization), the state has already reached a major milestone. 

 

Dispensaries drove the majority of those sales, but the milestone is thanks in part to the 54 Cannabis Grower Showcases (CGS), which allow licensed growers and processors to work with retailers to sell their products at events like farmers markets. Thus far, the CGS program has contributed $3.4 million in sales, helping expand cannabis access to even more New York City residents.

 

According to John Kagia, director of policy for New York State’s Office of Cannabis Management, the state’s regulated market is experiencing the “beginning of a rich brand diversification that’s only going to accelerate with more cultivation, processor, and distribution licenses” coming online in the future. Currently, there are 200-plus brands in the market and, as of November 2023, New York’s licensed retailers, on average, are carrying more than 50 brands. An estimated 72% of these dispensaries have more than 200 SKUs in their stores. 

 

“This is a critical milestone for the market. It continues to reflect an incredible retail velocity, and with the extraordinary effort that our retailers have put forth in getting the stores up, securing diverse products, and getting the customers in, we continue to see strong growth amongst the operators that we currently have,” Kagia added.

 

Stay informed with CWCBExpo

 

For the latest insights and connections, CWCBExpo remains your go-to source. Stay ahead of the curve by subscribing to our email newsletter or following us on Instagram, LinkedIn, Facebook, or Twitter (now X). And don’t forget to mark your calendars for our annual B2B conference in NYC, the prime opportunity to connect with fellow industry professionals, gain firsthand knowledge, and navigate the ever-evolving market. 

Loading...
Skip to content
Loading...
Skip to content